StockWatch
·

Oxygenta Pharmaceutical Ltd Q1 FY27 Results

OXYGENTAPHQ1 FY27 Results
Filing
Result:Weak· Market: Down#Base effect#Margin expansion
MetricValue (₹ Cr)Q4 FY26Q1 FY26
Revenue37.0025.4%144.4%
Total Income37.0225.6%141.9%
Expenditure39.5322.6%68.6%
PBT-2.5195.9%69.2%
Net Profit-2.1023.4%65.5%
OPM1.48%1.25pp46.68pp
NPM-5.68%2.26pp34.22pp
EPS0.5726.7%65.5%
View full financials

Revenue nearly doubled off a very small base and the operating margin swung from deeply negative to marginally positive, but the company remains in a net loss (not a turnaround), which caps the rating below good.

Informational and educational content only. Not investment advice.